NANETS treatment guidelines: Well-differentiated neuroendocrine tumors of the stomach and pancreas

501Citations
Citations of this article
170Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies. Copyright © 2010 by Lippincott Williams & Wilkins.

Cite

CITATION STYLE

APA

Kulke, M. H., Anthony, L. B., Bushnell, D. L., De Herder, W. W., Goldsmith, S. J., Klimstra, D. S., … Jensen, R. T. (2010, August). NANETS treatment guidelines: Well-differentiated neuroendocrine tumors of the stomach and pancreas. Pancreas. https://doi.org/10.1097/MPA.0b013e3181ebb168

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free